These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2154809)

  • 1. In vivo opioid activity of S-methyl and S-allyl morphinan derivatives.
    Jolicoeur FB; Ménard D; Belleau B; Lemaire S
    Prog Clin Biol Res; 1990; 328():49-52. PubMed ID: 2154809
    [No Abstract]   [Full Text] [Related]  

  • 2. Naloxone blocks the analgesic action of levorphanol but not of dextrorphan in the leopard frog.
    Stevens CW; Pezalla PD
    Brain Res; 1984 May; 301(1):171-4. PubMed ID: 6329442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of 14-alkoxymorphinans. 18. N-substituted 14-phenylpropyloxymorphinan-6-ones with unanticipated agonist properties: extending the scope of common structure-activity relationships.
    Greiner E; Spetea M; Krassnig R; Schüllner F; Aceto M; Harris LS; Traynor JR; Woods JH; Coop A; Schmidhammer H
    J Med Chem; 2003 Apr; 46(9):1758-63. PubMed ID: 12699394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
    Ananthan S; Khare NK; Saini SK; Seitz LE; Bartlett JL; Davis P; Dersch CM; Porreca F; Rothman RB; Bilsky EJ
    J Med Chem; 2004 Mar; 47(6):1400-12. PubMed ID: 14998329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure activity and receptor binding of antagonist analgesics [[proceedings].
    Lewis JW; Rance MJ
    Psychopharmacol Bull; 1981 Jan; 17(1):83-5. PubMed ID: 6262856
    [No Abstract]   [Full Text] [Related]  

  • 6. Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey.
    Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):245-52. PubMed ID: 2164093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vivo pharmacological analysis of benzomorphan binding sites in rats.
    Cowan A; Gmerek DE
    NIDA Res Monogr; 1984 Mar; 49():114-20. PubMed ID: 6090914
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of a novel bivalent morphinan possessing kappa agonist and micro agonist/antagonist properties.
    Mathews JL; Peng X; Xiong W; Zhang A; Negus SS; Neumeyer JL; Bidlack JM
    J Pharmacol Exp Ther; 2005 Nov; 315(2):821-7. PubMed ID: 16076937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syntheses of 4,6'-epoxymorphinan derivatives and their pharmacologies.
    Nemoto T; Fujii H; Narita M; Miyoshi K; Nakamura A; Suzuki T; Nagase H
    Bioorg Med Chem; 2008 Apr; 16(8):4304-12. PubMed ID: 18337104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple opioid receptors may mediate beta-casein-induced analgesia in neonatal rats.
    Giordano J; Doescher R
    Prog Clin Biol Res; 1990; 328():457-60. PubMed ID: 2154805
    [No Abstract]   [Full Text] [Related]  

  • 11. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperalgesia produced by intrathecal opioid antagonists depends on receptor selectivity and noxious stimulus.
    Pilcher CW; Browne JL
    NIDA Res Monogr; 1986; 75():469-72. PubMed ID: 2828994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cholinergic analgesia by (+)-opiates.
    Walker JM; Patrick SL; Thurkauf A; Rice KC; Bowen WD
    Prog Clin Biol Res; 1990; 328():81-4. PubMed ID: 2154824
    [No Abstract]   [Full Text] [Related]  

  • 14. Levallorphan and related compounds.
    Leimgruber W; Mohacsi E; Baruth H; Randall LO
    Adv Biochem Psychopharmacol; 1973; 8(0):45-50. PubMed ID: 4794970
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of morphine derivatives on lipid metabolism in Staphylococcus aureus.
    Gale EF
    Mol Pharmacol; 1970 Mar; 6(2):134-45. PubMed ID: 5418232
    [No Abstract]   [Full Text] [Related]  

  • 16. Diversified electrophysiological properties of morphinan drugs in rats.
    Sagratella S; Zeng YC; Frank C; de Carolis AS
    Gen Pharmacol; 1991; 22(2):231-6. PubMed ID: 1647341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and pharmacological evaluation of 6,7-indolo/thiazolo-morphinans--further SAR of levorphanol.
    Zhang A; Li F; Ding C; Yao Q; Knapp BI; Bidlack JM; Neumeyer JL
    J Med Chem; 2007 May; 50(11):2747-51. PubMed ID: 17488103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The increased efficacy of narcotic antagonists induced by various narcotic analgesics.
    Tulunay FC; Takemori AE
    J Pharmacol Exp Ther; 1974 Sep; 190(3):395-400. PubMed ID: 4416308
    [No Abstract]   [Full Text] [Related]  

  • 19. Structure-activity relationships of oxygenated morphinans. III. An exploration of the effect of the aromatic oxygen and 6-keto group on antinociceptive activity, receptor affinity, and narcotic antagonism.
    Jacobson AE; Schmidhammer H; Hsu FL; Rozwadowska MD; Atwell L; Brossi A; Aceto MD; Harris LS; Katz JL; Woods JH; Medzihradsky F
    NIDA Res Monogr; 1982 Apr; 41():86-92. PubMed ID: 6289121
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of diacetylmorphine and related morphinans on some biochemical activities of Staphylococcus aureus.
    Gale EF
    Mol Pharmacol; 1970 Mar; 6(2):128-33. PubMed ID: 5418231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.